Health Care

Fortrea Holdings insider trades reveal COO Morais’s cautious net purchase, signaling management confidence and a strategic growth outlook for investors.

Read how Baxter’s new CFO’s RSU award signals confidence amid a struggling share price, offering insight into leadership’s long‑term value strategy.

Vertex insider sales stay routine, with Chief Legal Officer Liu Joy selling 828 shares at $439.91—a 4 % drop in holdings but no impact on long‑term value.

Precision BioSciences insiders buy RSUs, signaling confidence amid a price dip and hinting at future upside from upcoming clinical milestones.

Definitive Healthcare CFO sells 164k shares for tax‑withholding, sparking 150% social‑media buzz—yet still holds 25% of the float, showing confidence amid a 75% YTD plunge.

ProQR insider buy‑options signal confidence in its rare‑disorder pipeline, offering investors a long‑term endorsement amid current market volatility and potential future upside.

HRT Financial’s recent $0.14 buy of 2.7m WORK Medical shares signals a “buy‑the‑dip” move amid a volatile, high‑risk stock—what traders need to watch.

AbCellera CFO’s bulk share buy signals bullish confidence: insider accumulation, strong earnings trend, and growing pipeline may boost short‑term stock performance.

CapsoVision CEO’s option exercise signals confidence in a strategic shift to high‑margin SaaS services, offering investors insight into upcoming margin expansion and recurring revenue growth.

Rodgers Thomas L’s June 1 sale of 123 McKesson shares is a routine insider liquidity move that highlights the company’s disciplined governance, strategic Apollo investment, and resilient healthcare distribution growth prospects.